Tenth Annual Immunogenicity Bioassay Summit
Date: October 22 - 25, 2018
Venue: Washington DC, USA

Sponsors View All Sponsors

AbMaxBiotechnology Collaborative-Drug-Discovery

Conferences


Celebrating 10 Years of Progress

Now in its 10th year, CHI’s Immunogenicity and Bioassay Summit will examine the challenges currently facing the industry and will provide NEW case studies, NEW perspectives and NEW approaches. You will hear from the industry, academia and the regulatory authorities. This year we present 3 Conference Programs, a Symposium, Training Seminar and many short courses for in-depth study, as well as interactive breakout discussions for sharing of experiences and ideas, and excellent networking opportunities.

2017 Event Stats:
  • 250+ Delegates from 145 Companies
  • 60 Speakers
  • 25 Posters Presented
  • 15 Countries Represented
  • 14 Exhibiting Companies
View the 2017 Attendee List

Testimonials

“This conference provides very deep and broad scientific presentations, roundtable discussions, and excellent networking opportunities for scientists, managers/directors, CROs, vendors and consultants.”
- Senior Group Leader, Pfizer

“The Immunogenicity and Bioassay Summit covers up-to-date research and regulatory advances on all aspects of immunogenicity. It’s a very good meeting for experts and newcomers to the field.”
- Senior Director, Head, Bioanalytical and Biomarker Development, Research & Nonclinical Development, Shire

“Program and participants first class.”
- Associate Director, Novo Nordisk

“Great to get regulatory perspectives on challenges and expectations. The higher level strategic discussions were very informative.”
- Beth Arnold, Director, Biologics & Vaccine Bioanalytics, Merck

“Breakout interaction with FDA experts was very valuable.”
- Associate Director, Alexion Pharmaceuticals Inc.

Keynote & Featured Speakers

Rakesh Dixit, PhD
Vice President, R&D, Global Head, Biologics Safety Assessment
MedImmune, Inc.
Theresa Goletz, PhD
Global Head NBE DD
EMD Serono
William Hallett, PhD
Biologist, OPQ/OBP
CDER, FDA
Timothy Hickling, PhD
Immunogenicity Sciences Lead, Biomedicine Design
Pfizer, Inc.
little_thomasThomas Little, PhD
President and CEO, Bioassay Sciences
Thomas A. Little Consulting
Ira Pastan, MD
Co-Chief, Molecular Biology, National Cancer Institute
National Institutes of Health
Timothy Schofield
Senior Advisor, Technical Research & Development
GSK
Ethan Shevach, MD
Senior Investigator, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
NIH
Perceval Sondag
Senior Manager, Statistics
PharmaLex
Joleen T. White, PhD
Director, Head of Project Support, NBE Drug Disposition
EMD Serono


Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean